Early time of day of administration of immunochemotherapy for enhancing overall survival in patients with lung cancer irrespective of histological type?
The striking clinical relevance of the circadian immune system for patients with advanced lung cancer is supported by consistent overall survival prolongation through early time of day of immunochemotherapy, no matter the histological type.
Authors
- F. LEVI
Institutions
- Inserm (FR)
- University of Warwick (GB)
- Hôpital Paul-Brousse (FR)
Publication Details
- Journal
- Cancer
- Published
- 2026-02-05
- DOI
- https://doi.org/10.1002/cncr.70290
- Primary Topic
- Circadian rhythm and melatonin
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Institut National de la Santé et de la Recherche Médicale